Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-05-30 00:00:00 ET · period of report 2025-05-29 · accession 0001562180-25-004279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-05-30 | 2025-05-29 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $316.07 | -11.0K | 41.9K | -21% | -$3.48M |
| DMT | 2025-05-30 | 2025-05-29 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $129.00 | +11.0K | 47.8K | +30% | +$1.42M |
| DMT | 2025-05-30 | 2025-05-29 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -11.0K | 143.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-29 | S | D | 4,000 | $315.77 | 43,781 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-29 | S | D | 4,573 | $316.57 | 37,305 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $316.07 to $317.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-05-29 | M | A | 7,000 | $135.42 | 43,781 | D | — | — | |
| 4 | Common | Common Stock | 2025-05-29 | M | A | 4,000 | $117.76 | 47,781 | D | — | — | |
| 5 | Common | Common Stock | 2025-05-29 | S | D | 524 | $317.19 | 36,781 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $317.11 to $317.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2025-05-29 | S | D | 99 | $311.14 | 43,682 | D | — | — | |
| 7 | Common | Common Stock | 2025-05-29 | S | D | 101 | $313.46 | 43,581 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $312.73 to $313.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2025-05-29 | S | D | 1,703 | $315.53 | 41,878 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $315.07 to $316.055. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Derivative | Stock Option | 2025-05-29 | M | D | 4,000 | $0.00 | 0 | D | $117.76 · 2023-05-15 to 2027-03-15 | 4,000 Common Stock | |
| 10 | Derivative | Stock Option | 2025-05-29 | M | D | 7,000 | $0.00 | 143,000 | D | $135.42 · 2023-03-15 to 2027-03-15 | 7,000 Common Stock |